To further characterize the phenotype of Mtb-specific IFNγ+CD4+ T-cell responses, we compared the activation profile (HLA-DR) and cytotoxic potential (granzyme B) between TB-IRIS patients and non-IRIS controls. The gene discussed is CD4; the disease is tuberculosis.